Filing Details

Accession Number:
0000937556-20-000081
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-04-15 19:12:30
Reporting Period:
2020-04-14
Accepted Time:
2020-04-15 19:12:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
937556 Masimo Corp MASI Electromedical & Electrotherapeutic Apparatus (3845) 330368882
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1442689 Jon Coleman C/O Masimo Corporation
52 Discovery
Irvine CA 92618
Pres-Ww Sales,Pro Svc,Med Affs No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-04-14 2,000 $28.03 14,465 No 4 M Direct
Common Stock Disposition 2020-04-14 2,000 $190.00 12,465 No 4 S Direct
Common Stock Acquisiton 2020-04-15 2,000 $28.03 14,465 No 4 M Direct
Common Stock Disposition 2020-04-15 2,000 $195.00 12,465 No 4 S Direct
Common Stock Acquisiton 2020-04-15 2,000 $28.03 14,465 No 4 M Direct
Common Stock Disposition 2020-04-15 2,000 $200.00 12,465 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (Right to Buy) Disposition 2020-04-14 2,000 $28.03 2,000 $28.03
Common Stock Non-Qualified Stock Option (Right to Buy) Disposition 2020-04-15 2,000 $28.03 2,000 $28.03
Common Stock Non-Qualified Stock Option (Right to Buy) Disposition 2020-04-15 2,000 $28.03 2,000 $28.03
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,000 2015-02-18 2024-02-18 No 4 M Direct
2,000 2015-02-18 2024-02-18 No 4 M Direct
0 2015-02-18 2024-02-18 No 4 M Direct
Footnotes
  1. The shares covered by this Form 4 were exercised and sold pursuant to a Rule 10b5-1 Sales Plan dated as of March 12, 2020, which is intended to comply with Rule 10b5-1 promulgated under the SecuritiesExchange Act of 1934, as amended.
  2. This option was granted on February 18, 2014 and is exercisable as the option vests. This option vested over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grantdate.